Advertisement

International Ophthalmology

, Volume 39, Issue 2, pp 465–470 | Cite as

Intravitreal dexamethasone implant with retinal photocoagulation for adult-onset Coats’ disease

  • Kshitiz KumarEmail author
  • Pallavi Raj
  • Nisha Chandnani
  • Amar Agarwal
Case Report
  • 125 Downloads

Abstract

Purpose

To report a case of adult-onset Coats’ disease with secondary retinal vasoproliferative tumor managed with dexamethasone intravitreal implant and retinal photocoagulation.

Methods

Case study.

Results

A 41-year-old female with counting finger vision was diagnosed with Coats’ disease with secondary retinal vasoproliferative tumor in right eye. Fundus examination revealed exudative retinopathy involving posterior pole and a retinal tumor located in the inferotemporal quadrant. Optical coherence tomography scan confirmed massive exudative neurosensory detachment and fundus fluorescein angiography showed areas of telangiectatic vessels with capillary non-perfusion. Intravitreal injection of dexamethasone implant was done initially followed by laser photocoagulation when the detachment resolved. There was significant improvement in patient’s visual acuity with no further recurrence of exudation.

Conclusion

Intravitreal dexamethasone implant Ozurdex(®) (Allergan, Inc., Irvine, Calif., USA) may be an effective initial therapeutic approach for Coats’ disease with massive exudation.

Keywords

Exudative vitreo-retinopathy Idiopathic retinal telangiectasia Intravitreal steroid implant Retinal vasoproliferative tumor 

Notes

Acknowledgements

Authors do not have any proprietary interest in this article. This research was not funded and is the sole work of the authors.

References

  1. 1.
    Shields JA, Shields CL, Honavar SG, Demirci H (2001) Clinical variations and complications of Coats’ disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture. Am J Ophthalmol 131:561–571CrossRefGoogle Scholar
  2. 2.
    Smithen LM, Brown GC, Brucker AJ, Yannuzzi LA, Klais CM, Spaide RF (2005) Coats’ disease diagnosed in adulthood. Ophthalmology 112:1072–1078CrossRefGoogle Scholar
  3. 3.
    Shields JA, Shields CL, Honavar SG, Demirci H, Cater J (2001) Classification and management of Coats disease: the 2000 Proctor Lecture. Am J Opthalmol 131:572–583CrossRefGoogle Scholar
  4. 4.
    Bergstrom CS, Hubbard GB 3rd (2008) Combination intravitreal triamcinolone injection and cryotherapy for exudative retinal detachments in severe Coats disease. Retina 28(3 suppl):S33–S37CrossRefGoogle Scholar
  5. 5.
    Othman IS, Moussa M, Bouhaimed M (2010) Management of lipid exudates in Coats disease by adjuvant intravitreal triamcinolone: effects and complications. Br J Ophthalmol 94:606–610CrossRefGoogle Scholar
  6. 6.
    Venkatesh P, Mandal S, Garg S (2008) Management of Coats disease with bevacizumab in 2 patients. Can J Ophthalmol 43:245–246CrossRefGoogle Scholar
  7. 7.
    Goel N, Kumar V, Seth A, Raina UK, Ghosh B (2011) Role of intravitreal bevacizumab in adult onset Coats’ disease. Int Ophthalmol 31:183–190CrossRefGoogle Scholar
  8. 8.
    Martinez-Castillo S, Gallego-Pinazo R, Dolz-Marco R, Marin-Lambíes C, Diaz-Llopis M (2012) Adult Coats’ disease successfully managed with the dexamethasone intravitreal implant (ozurdex®) combined with retinal photocoagulation. Case Rep Ophthalmol 3:123–127CrossRefGoogle Scholar
  9. 9.
    Saatci AO, Doruk HC, Yaman A (2013) Intravitreal dexamethasone implant (ozurdex) in coats’ disease. Case Rep Ophthalmol 4(3):122–128CrossRefGoogle Scholar
  10. 10.
    Shields JA, Shields CL (2002) Coats’ disease: the 2001 Lu Esther T. Mertz lecture. Retina 22:80–91CrossRefGoogle Scholar
  11. 11.
    Shields CL, Shields JA, Barrett J, De Potter P (1995) Vasoproliferative tumors of the ocular fundus: classification and clinical manifestations in 103 patients. Arch Ophthalmol 113:615–623CrossRefGoogle Scholar
  12. 12.
    Jonas JB, Holbach LM (2001) Clinical-patho- logic correlation in Coats’ disease. Graefes Arch Clin Exp Ophthalmol 239:544–545CrossRefGoogle Scholar
  13. 13.
    Zhao T, Wang K, Ma Y, Jiang YR (2011) Resolution of total retinal detachment in Coats disease with intravitreal injection of bevacizumab. Graefes Arch Clin Exp Ophthalmol 249:1745–1746CrossRefGoogle Scholar
  14. 14.
    Ramasubramanian A, Shields CL (2012) Bevacizumab for Coats disease with exudative retinal detachment and risk of vitreoretinal traction. Br J Ophthalmol 96:356–359CrossRefGoogle Scholar
  15. 15.
    Roh MI, Kim HS, Song JH, Lim JB, Koh HJ, Kwon OW (2009) Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed CNV associated with AMD after bevacizumab treatment. Retina 29:523–529CrossRefGoogle Scholar
  16. 16.
    Roh MI, Lim SJ, Ahn JM, Lim JB, Kwon OW (2010) Concentration of cytokines in age—related macular degeneration after consecutive intravitreal bevacizumab injection. Graefes Arch Clin Exp Ophthalmol 248:635–640CrossRefGoogle Scholar
  17. 17.
    Park SP, Ahn JK, Mun GH (2010) Aqueous vascular endothelial growth factor levels are associated with serous macular detachment secondary to branch retina vein occlusion. Retina 30:281–286CrossRefGoogle Scholar
  18. 18.
    Arevalo JF, Maia M, Flynn HW Jr (2008) Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol 92:213–216CrossRefGoogle Scholar
  19. 19.
    Lim WK, Nussenblatt RB, Chan CC (2005) Immunopathologic features of inflammatory coats disease. Arch Ophthalmol 123:279–28120CrossRefGoogle Scholar
  20. 20.
    Tamura H, Miyamoto K, Kiryu J, Miyahara S, Katsuta H, Hirose F, Musashi K, Yoshimura N (2005) Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest Ophthalmol Vis Sci 46:1440–1444CrossRefGoogle Scholar
  21. 21.
    Ray R, Barañano DE, Hubbard GB (2013) Treatment of Coats’ disease with intravitreal bevacizumab. Br J Ophthalmol 97:272–277CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V., part of Springer Nature 2018

Authors and Affiliations

  • Kshitiz Kumar
    • 1
    Email author
  • Pallavi Raj
    • 1
  • Nisha Chandnani
    • 2
  • Amar Agarwal
    • 2
  1. 1.Dr. Agarwal’s Eye HospitalKolkataIndia
  2. 2.Dr. Agarwal’s Eye HospitalChennaiIndia

Personalised recommendations